• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STAAR SURGICAL COMPANY IMPLANTABLE COLLAMER LENS (ICL); PHAKIC INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STAAR SURGICAL COMPANY IMPLANTABLE COLLAMER LENS (ICL); PHAKIC INTRAOCULAR LENS Back to Search Results
Model Number VTICM5_12.6
Device Problem Device Operates Differently Than Expected (2913)
Patient Problems Corneal Edema (1791); Edema (1820); Pain (1994); Blurred Vision (2137); No Code Available (3191)
Event Date 07/03/2017
Event Type  Injury  
Manufacturer Narrative
This product is not marketed in the us.(b)(4).Work order search: no similar complaints were reported for units within the same lot.(b)(4).
 
Event Description
The reporter indicated that the surgeon implanted a 12.6 mm vticm5_12.6, -4.5/1.5/86 diopter, implantable collamer lens in the patient's left eye (os) on (b)(6) 2017.The next day, signs of toxic anterior segment syndrome, include tearing, pain, blurry vision, eyelid edema, hyperemia, corneal edema, fixed pupil and fibrin clot in the anterior chamber was noticed.Therapy was started with oral prednisolone (60 mg/day) and acetazolamide 250 mm (1+1+1), tropical prednisolone 1 drop per hour, trapicamide, ofloxacine, and bromofenac.The following day, the patient experience less pain, intense hyperemia, less eyelid edema but a very cloudy whitish cornea.Corneal periphery was partially pared and a blood clot was seen in the inferior a.C.An anterior chamber washing was performed as well as the temporal incision witch being sutured with 2 10/00 nylon stiches and intravitreous injection of vancomicine 1mg/0.1 ml and ceftazidime 1.0 mg/0.1 ml.According to the surgeon, the cornea is clearing up and would need to make another surgery to remove the membrane.
 
Manufacturer Narrative
Device history record (dhr) review: based on the results of the investigation, all released devices from the associated work order(s), including the suspected device, have been manufactured within established process parameters; and there is no indication that the manufacturing and processing of the device contributed to the complaint issue.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMPLANTABLE COLLAMER LENS (ICL)
Type of Device
PHAKIC INTRAOCULAR LENS
Manufacturer (Section D)
STAAR SURGICAL COMPANY
1911 walker avenue
monrovia CA 91016
Manufacturer (Section G)
STAAR SURGICAL COMPANY
1911 walker avenue
monrovia CA 91016
Manufacturer Contact
michelle andres
1911 walker avenue
monrovia, CA 91016
MDR Report Key6760836
MDR Text Key81626086
Report Number2023826-2017-01145
Device Sequence Number1
Product Code MTA
Combination Product (y/n)N
Reporter Country CodePO
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,health pr
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/03/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date02/29/2020
Device Model NumberVTICM5_12.6
Device Catalogue NumberN/A
Device Lot NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 07/03/2017
Initial Date FDA Received08/02/2017
Supplement Dates Manufacturer Received08/10/2017
Supplement Dates FDA Received09/01/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/16/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age30 YR
-
-